GlassScriptPhysician profile
Anna D Desaix
NPI 1578678066
$3,102.88
in general payments reported to CMS, 2019-2025
26 companies · $62.17 in 2025
The $62.17 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $561 · 2021: $1,423 · 2022: $276 · 2023: $34.24 · 2024: $18.97 · 2025: $62.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $115.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $571.62 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $428.61 | 2019-2022 | |
| Integra Lifesciences Corporation | $276.36 | 2019-2022 | |
| Elite Orthopedics, LLC | $248.42 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $234.63 | 2019-2022 | |
| Abbott Laboratories | $195.36 | 2019-2020 | |
| Stryker Corporation | $190.23 | 2021-2022 | |
| Abbvie INC. | $160.78 | 2021 | |
| Wright Medical Technology, INC. | $123.89 | 2019-2020 | |
| Vifor Pharma, INC. | $83.67 | 2019-2022 | |
| Bioventus LLC | $81.14 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Biocomposites INC | $72.70 | 2019 | |
| Opko Pharmaceuticals, LLC | $57.93 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $57.82 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $37.64 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veryan Medical Incorporated | $37.48 | 2021 | |
| Fresenius USA Marketing, INC. | $31.53 | 2019 | |
| Misonix INC | $31.39 | 2019-2020 | |
| Shire North American Group INC | $30.76 | 2019 | |
| Orthofix Medical, INC. | $26.26 | 2019 | |
| Mallinckrodt Enterprises LLC | $25.38 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.24 | 2022 | |
| Arteriocyte Medical Systems, INC. | $23.90 | 2020 | |
| Smith+Nephew, INC. | $19.50 | 2019 | |
| Horizon Therapeutics Plc | $15.80 | 2021 | |
| Melinta Therapeutics, LLC | $14.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Desaix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.